Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity

Blood. 2007 Jan 1;109(1):85-92. doi: 10.1182/blood-2006-05-020289.

Abstract

Regulatory molecules produced by stromal cells are often membrane bound until cleaved by matrix metalloproteinases (MMPs); cleavage can either activate or inactivate regulatory functions. We report here that marrow stromal cells induce the expression of MMP-9 in monocytes. Induction was contact independent and could be reproduced with recombinant MCP-1/CCL2, whereas IL-6, M-CSF, G-CSF, GM-CSF, IL-8/CXCL8, SDF-1/CXCL12, and MGSA/CXCL1 did not have this effect. Stroma-induced levels of MMP-9 in the monocyte population from healthy donors were relatively consistent, whereas induced levels varied significantly (P < .001) in the CD14+ population from 27 patients with myelodysplastic syndrome (MDS). In patients with a clonal chromosomal marker, the level of inducible MMP-9 expression in the monocyte population was inversely correlated with the percentage of marker-positive cells (n = 11, P = .01), suggesting that the ability to induce MMP-9 may be compromised in clonally derived monocytes. The inducible levels of MMP-9 were also inversely correlated with marrow cellularity observed in biopsies from MDS patients (P < .001). We conclude that monocytes can express MMP-9 in response to stromal factors and that this response may be significantly decreased in MDS-derived monocytes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bone Marrow / pathology*
  • Cells, Cultured / metabolism
  • Chemokines / pharmacology
  • Culture Media, Conditioned / pharmacology
  • Cytokines / pharmacology
  • Enzyme Induction
  • Female
  • Fibroblasts / metabolism
  • Humans
  • In Situ Hybridization, Fluorescence
  • Lipopolysaccharide Receptors / analysis
  • Male
  • Matrix Metalloproteinase 9 / biosynthesis*
  • Matrix Metalloproteinase 9 / genetics
  • Middle Aged
  • Monocytes / drug effects
  • Monocytes / enzymology*
  • Monocytes / pathology
  • Myelodysplastic Syndromes / enzymology*
  • Myelodysplastic Syndromes / pathology
  • RNA, Messenger / biosynthesis
  • Recombinant Proteins / pharmacology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stromal Cells / metabolism

Substances

  • Chemokines
  • Culture Media, Conditioned
  • Cytokines
  • Lipopolysaccharide Receptors
  • RNA, Messenger
  • Recombinant Proteins
  • Matrix Metalloproteinase 9